Champion Inds (NASDAQ:CHMP)
CHMP News and Commentary
- ALTH Seeks Review of Folotyn Verdict - Analyst Blog – NASDAQ
- Label Expansion for Merck KGaA Drug - Analyst Blog – NASDAQ
- Label Expansion for Merck KGaA Drug - Analyst Blog – NASDAQ
- Novartis Drugs Backed by CHMP - Analyst Blog – NASDAQ
- Positive CHMP Rec for Merck's Remicade - Analyst Blog – NASDAQ
- European Setback for Allos - Analyst Blog – NASDAQ
- AMAG Q4 Sales Set to Disappoint - Analyst Blog – NASDAQ
- BioMarin's Facility Expansion Backed - Analyst Blog – NASDAQ
- Roche's Cancer Drug Finds Support - Analyst Blog – NASDAQ
This ticker is not currently Ratable.
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPSAll Players
0
Outperform
0
Underperform
All-Star Players
0
Outperform
0
Underperform
Wall Street
0
Outperform
0
Underperform



RSS Headlines
Fool UK